Breztri Aerosphere budesonide 160 mcg, glycopyrrolate 9.0 mcg, and formoterol fumarate 4.8 mcg per inhalation Images
Generic Name: budesonide/formoterol/glycopyrrolate
This medication has been identified as Breztri Aerosphere budesonide 160 mcg, glycopyrrolate 9.0 mcg, and formoterol fumarate 4.8 mcg per inhalation. It is supplied by AstraZeneca.
Breztri Aerosphere is used in the treatment of COPD, Maintenance; COPD and belongs to the drug class bronchodilator combinations. Breztri Aerosphere budesonide 160 mcg, glycopyrrolate 9.0 mcg, and formoterol fumarate 4.8 mcg per inhalation is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Breztri Aerosphere
- Generic Name
- budesonide/formoterol/glycopyrrolate
- Strength
- budesonide 160 mcg, glycopyrrolate 9.0 mcg, and formoterol fumarate 4.8 mcg per inhalation
- Availability
- Prescription only
- Drug Class
- Bronchodilator combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-4616
More about Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (109)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bronchodilator combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.